Provided by Tiger Trade Technology Pte. Ltd.

Bio-Techne

57.85
+0.86001.51%
Post-market: 57.850.00000.00%16:10 EST
Volume:2.19M
Turnover:126.41M
Market Cap:9.01B
PE:111.41
High:58.07
Open:57.80
Low:56.92
Close:56.99
52wk High:72.16
52wk Low:46.01
Shares:155.81M
Float Shares:154.93M
Volume Ratio:1.08
T/O Rate:1.42%
Dividend:0.32
Dividend Rate:0.55%
EPS(TTM):0.5193
EPS(LYR):0.4600
ROE:3.97%
ROA:6.52%
PB:4.48
PE(LYR):125.76

Loading ...

Bio-Techne Exec Says Modest Decline in Co's US Academic Business Was Partially Offset by Stable Growth in Europe - Conf Call

THOMSON REUTERS
·
Feb 04

Stock Track | Bio-Techne Soars 5.04% in Pre-Market on Better-Than-Expected Quarterly Results

Stock Track
·
Feb 04

Bio-Techne Declares Quarterly Dividend of $0.08 a Share, Payable Feb. 27 to Shareholders of Record on Feb. 16

MT Newswires Live
·
Feb 04

Biotech firm Bio-Techne beats quarterly estimates on strength in key unit

Reuters
·
Feb 04

Bio-Techne Q2 revenue, adjusted EPS beat estimates on China/APAC growth

Reuters
·
Feb 04

Bio-Techne meldet für das zweite Quartal ein bereinigtes Ergebnis je Aktie von 0,46 USD mit einem Anstieg von 9,5 Prozent

Reuters
·
Feb 04

BRIEF-Bio-Techne Q2 Adjusted EPS USD 0.46 Vs. IBES Estimate USD 0.43

Reuters
·
Feb 04

Bio-Techne Corporation announces $0.08 quarterly dividend

Reuters
·
Feb 04

Bio-Techne Corp - Announces Dividend of $0.08 per Share for Q4 2025

THOMSON REUTERS
·
Feb 04

Bio-Techne Q2 Pretax Profit USD 50.784 Million

THOMSON REUTERS
·
Feb 04

Bio-Techne Releases Second Quarter Fiscal 2026 Results

THOMSON REUTERS
·
Feb 04

Bio-Techne Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 03

Bio-Techne Launches Cultrex Synthetic Hydrogel to Support 3D Stem Cell, Organoid Research

MT Newswires Live
·
Feb 02

BRIEF-Bio-Techne Expands 3D Stem Cell & Organoid Culture Portfolio

Reuters
·
Feb 02

Bio-Techne launches Cultrex Synthetic Hydrogel

TIPRANKS
·
Feb 02

Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio With a Fully Defined Synthetic Alternative

THOMSON REUTERS
·
Feb 02

Bio-Techne Corp. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Jan 29

Bio-Techne Unveils Ultra-Sensitive Assays for Early Detection of Neurological Biomarkers

Reuters
·
Jan 29

Earning Preview: Bio-Techne’s quarterly revenue is expected to increase by 1.56%, and institutional views are leaning positive

Earnings Agent
·
Jan 28

Is Bio-Techne’s (TECH) Spatial Biology Push Under New CEO Quietly Redefining Its Core Strategy?

Simply Wall St.
·
Jan 24